Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial-Reference-Cited by-同舟云学术

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial

Published:2018-04 Issue:4 Volume:19 Page:451-460
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Choueiri Toni K,Larkin James,Oya Mototsugu,Thistlethwaite Fiona,Martignoni Marcella,Nathan Paul,Powles Thomas,McDermott David,Robbins Paul B,Chism David D,Cho Daniel,Atkins Michael B,Gordon Michael S,Gupta Sumati,Uemura Hirotsugu,Tomita Yoshihiko,Compagnoni Anna,Fowst Camilla,di Pietro Alessandra,Rini Brian I

Publisher

Elsevier BV

Subject

Oncology

Reference22 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Current and future systemic treatments for renal cell carcinoma;Fisher;Semin Cancer Biol,2013

3. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

4. Targeted therapies for treatment of renal cell carcinoma: recent advances and future perspectives;Minguet;Cancer Chemother Pharmacol,2015

5. Sunitinib and other targeted therapies for renal cell carcinoma;Powles;Br J Cancer,2011

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of PD 1/PD L1 Inhibitors in the Treatment of Urological Tumors;Current Cancer Drug Targets;2024-11

2. Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations;Kidney Cancer;2024-09-05

3. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

4. Single‐cell transcriptomics reveals antigen‐presenting capacity and therapeutic resistance potential of immunomodulatory endothelial cells in colorectal cancer;Immunity, Inflammation and Disease;2024-06

5. Machine learning–based integration develops a stress response stated T cell (Tstr)–related score for predicting outcomes in clear cell renal cell carcinoma;International Immunopharmacology;2024-05